Neurofibromatosis type 1: Difference between revisions
(Blanked the page) Tag: Blanking |
MoisesRomo (talk | contribs) No edit summary |
||
| (4 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | |||
{{Neurofibromatosis type 1}} | |||
'''For patient information, click [[Neurofibromatosis type 1 (patient information)|here]]''' | |||
{{CMG}}; {{AE}}[[User:MoisesRomo|Moises Romo, M.D.]] | |||
{{SK}}[[neurofibromatosis type 1]], [[NF1|NF1 gene]], [[neurofibroma]], [[neurofibromin]], [[prevalence]], [[incidence]] | |||
==[[Neurofibromatosis type 1 overview|Overview]]== | |||
==[[Neurofibromatosis type 1 historical perspective|Historical Perspective]]== | |||
==[[Neurofibromatosis type 1 classification|Classification]]== | |||
==[[Neurofibromatosis type 1 pathophysiology|Pathophysiology]]== | |||
==[[Neurofibromatosis type 1 causes|Causes]]== | |||
==[[Neurofibromatosis type 1 differential diagnosis|Differentiating neurofibromatosis type 1 from other Diseases]]== | |||
==[[Neurofibromatosis type 1 epidemiology and demographics|Epidemiology and Demographics]]== | |||
==[[Neurofibromatosis type 1 risk factors|Risk Factors]]== | |||
==[[Neurofibromatosis type 1 screening|Screening]]== | |||
==[[Neurofibromatosis type 1 natural history, complications and prognosis|Natural History, Complications and Prognosis]]== | |||
==Diagnosis== | |||
[[Neurofibromatosis type 1 diagnostic study of choice|Diagnostic study of choice]] | [[Neurofibromatosis type 1 history and symptoms|History and Symptoms]] | [[Neurofibromatosis type 1 physical examination|Physical Examination]] | [[Neurofibromatosis type 1 laboratory findings|Laboratory Findings]] | [[Neurofibromatosis type 1 electrocardiogram|Electrocardiogram]] | [[Neurofibromatosis type 1 x ray|X-Ray Findings]] | [[Neurofibromatosis type 1 echocardiography and ultrasound|Echocardiography and Ultrasound]] | [[Neurofibromatosis type 1 CT scan|CT-Scan Findings]] | [[Neurofibromatosis type 1 MRI|MRI Findings]] | | [[Neurofibromatosis type 1 other diagnostic studies|Other Diagnostic Studies]] | |||
==Treatment== | |||
[[Neurofibromatosis type 1 medical therapy|Medical Therapy]] | [[Neurofibromatosis type 1 interventions|Interventions]] | [[Neurofibromatosis type 1 surgery|Surgery]] | [[Neurofibromatosis type 1 primary prevention|Primary Prevention]] | [[Neurofibromatosis type 1 secondary prevention|Secondary Prevention]] | [[Neurofibromatosis type 1 cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Neurofibromatosis type 1 future or investigational therapies|Future or Investigational Therapies]] | |||
==Case Studies== | |||
[[Neurofibromatosis type 1 case study one|Case #1]] | |||
[[Category: (name of the system)]] | |||
Latest revision as of 04:14, 1 July 2020
|
Neurofibromatosis type 1 Microchapters |
|
Differentiating Neurofibromatosis type 1 from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Neurofibromatosis type 1 On the Web |
|
American Roentgen Ray Society Images of Neurofibromatosis type 1 |
|
Risk calculators and risk factors for Neurofibromatosis type 1 |
For patient information, click here
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Moises Romo, M.D.
Synonyms and keywords:neurofibromatosis type 1, NF1 gene, neurofibroma, neurofibromin, prevalence, incidence
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating neurofibromatosis type 1 from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic study of choice | History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | X-Ray Findings | Echocardiography and Ultrasound | CT-Scan Findings | MRI Findings | | Other Diagnostic Studies
Treatment
Medical Therapy | Interventions | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies